APOBEC3B Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14542
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.81 mg/ml
Product Specifications
Immunogen
Synthetic peptide
Clonality
Polyclonal
Host
Rabbit
Description
Product can be stored undiluted at 4C for up to 1 month.
Scientific Data Images for APOBEC3B Antibody - BSA Free
Immunohistochemistry-Paraffin: APOBEC3B Antibody [NBP3-14542]
Immunohistochemistry-Paraffin: APOBEC3B Antibody [NBP3-14542] - Human Breast Carcinoma: Formalin-Fixed, Paraffin-Embedded (FFPE)Applications for APOBEC3B Antibody - BSA Free
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.1% Sodium Azide
Concentration
0.81 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles.
Background: APOBEC3B
Alternate Names
APOBEC1L, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B, ARCD3, ARP4, bK150C2.2, cytidine deaminase, DJ742C19.2, EC 3.5.4, EC 3.5.4.-, FLJ21201, phorbolin 3, Phorbolin-1-related protein, Phorbolin-2/3, PHRBNLphorbolin 2, probable DNA dC->dU-editing enzyme APOBEC-3B
Gene Symbol
APOBEC3B
Additional APOBEC3B Products
Product Documents for APOBEC3B Antibody - BSA Free
Product Specific Notices for APOBEC3B Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...